ReviewJournal of the Society for Cardiovascular Angiography & Interventions2026
Long Femoropopliteal Lesions Challenge the Limits of Endovascular Technique: Contemporary Systematic Review and Meta-analysis.
Review in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Durability of the DETOUR System for Long and Complex Femoral-Popliteal Lesions: 3-Year Results From the DETOUR2 Trial.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Traditionally, patients with symptomatic femoropopliteal artery occlusive disease have been treated surgically. However, a growing body of clinical evidence has emerged supporting endovascular treatment in patients with long lesions. The objective of this systematic search and meta-analysis was to assess contemporary outcomes in patients undergoing endovascular treatment for long femoral-popliteal lesions. Methods: An updated systematic search of Embase, including MEDLINE, identified relevant records published between January 2000 and March 2023 reporting a minimum of 1-year follow-up of endovascular revascularization in patients with mean lesion length ≥20 cm. A pooled meta-analysis was performed using a random-effects model for all longitudinal cumulative event rates. Subgroup analyses explored stratification by lesion length, intervention, study design, and outcome definition. Quality of evidence and risk of bias assessments were conducted. Results: A total of 28 records, 2338 limbs, and 2311 patients, were analyzed. The pooled cumulative event rates (95% CI) for primary patency were as follows: 0.85 (95% CI, 0.81-0.89), 0.67 (95% CI, 0.61-0.73), 0.48 (95% CI, 0.38-0.57), and 0.42 (95% CI, 0.33-0.52); secondary patency: 0.90 (95% CI, 0.85-0.93), 0.84 (95% CI, 0.77-0.89), 0.72 (95% CI, 0.64-0.78), 0.63 (95% CI, 0.52-0.73); and freedom from target lesion revascularization: 0.93 (95% CI, 0.89-0.96), 0.79 (95% CI, 0.74-0.83), 0.68 (95% CI, 0.62-0.73), and 0.63 (95% CI, 0.57-0.69) at 6, 12, 24, and 36 months, respectively. Select subgroup analyses showed clinically relevant variation in event rates. Conclusions: This systematic search and meta-analysis provides important insight into the performance of endovascular revascularization in patients with long lesions. These findings will need to be considered as treatment decisions are made.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.